Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Bain Capital Life Sciences

Status
ACTIVE
Global HQ
Boston, United States
Countries of investment
  • USA
Investment stages
  • Seed
Industries
  • Pharma
  • Diagnostics
  • Biotechnology
  • Health Tech
About
Bain Capital Life Sciences leverages industry expertise and cross-asset class investing to advance pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools. Partnering globally, they drive medical innovation to address unmet medical needs.
Min check size
$10M
Max check size
$50M
Fund size
NPS

Investment Thesis

Bain Capital Life Sciences targets inflection points where capital and expertise can drive transformational growth. They focus on pharmaceuticals, biotechnology, medical devices, diagnostics, and life science tools.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Specializing in technology investments, the fund manager has navigated diverse sectors, including health tech and renewable energy. Focused on early-stage ventures, they have successfully concluded over 40 deals, demonstrating a strong presence in the North American market. Renowned for a balanced investment style, they emphasize both growth potential and sustainable practices. Their strategic approach has led to multiple high-profile exits, solidifying their reputation within the top-tier investment community.
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp